Understanding The Potential Drug Target Or Biomarker LINC03034

Target Name: LINC03034

NCBI ID: G283710

LINC03034

Other Name(s): Uncharacterized LOC283710 | long intergenic non-protein coding RNA 3034 | LOC283710 | Uncharacterized protein LOC283710

Understanding The Potential Drug Target Or Biomarker LINC03034

LINC03034 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is derived from the gene encoding the long non-coding RNA (lnc) protein LINC01034. LINC03034 is characterized by its unique structure, which consists of a cluster of 11 exons that are predominantly transcribed from the 5' end of the gene.

The primary function of LINC03034 is not well understood, but it is involved in various cellular processes such as cell adhesion, migration, and survival. It has been shown to play a role in the regulation of cell cycle progression, and has been associated with the development and progression of various diseases, including cancer.

One of the key features of LINC03034 is its ability to interact with various signaling pathways, including TGF-β, NF-kappa-B, and Hedgehog. It has been shown to play a role in the regulation of these pathways, and is therefore considered A potential drug target.

LINC03034 has also been shown to be involved in the regulation of gene expression. It has been shown to interact with various proteins, including STAT3, a transcription factor that plays a critical role in the regulation of gene expression. This interaction between LINC03034 and STAT3 suggests that it may be a useful biomarker for the evaluation of STAT3-mediated signaling pathways.

Another potential mechanism by which LINC03034 may be involved in the regulation of gene expression is its role in the regulation of microRNA (miRNA) levels. MIRNA is a small non-coding RNA molecule that plays a critical role in the regulation of gene expression. LINC03034 has been shown to interact with miRNA, and this interaction may play a role in the regulation of miRNA levels.

In conclusion, LINC03034 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and various cellular processes that it is involved in suggest that it may be a useful target for the development of new therapeutic strategies for various diseases. Further research is needed to fully understand the role of LINC03034 in the regulation of gene expression and its potential as a drug target.

Protein Name: Long Intergenic Non-protein Coding RNA 3034

The "LINC03034 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC03034 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets